Streptococcus pyogenes bacteraemia - The impact of previous radiation and clindamycin resistance

QJM: An International Journal of Medicine

Volumn 89, Issue 5, 1996, Pages 369-375

  Shih, C C ^a,b   Chen, Y C ^a   Chang, S C ^a   Luh, K T ^a   Lee, C Y ^a   Hsieh, W C ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Sun Yat Sen Cancer Center   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CHILD; CLINICAL ARTICLE; CROSS RESISTANCE; DISEASE PREDISPOSITION; FEMALE; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; SOLID TUMOR; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; TAIWAN; TOXIC SHOCK SYNDROME;

EID: 0029943048     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hable KA, Horstmeier C, Wold AD, Washington JA II. Group A β-hemolytic streptococcemia: bacteriologic and clinical study of 44 cases. Mayo Clin Proc 1973; 48:336-9.
2. Francis J, Warren RE. Streptococcuspyogenes bacteraemia in Cambridge - a review of 67 episodes. QJ Med 1988; 68:603-13.
3. Burket T, Watanakunakorn C. Group A streptococcal bacteremia in a community teaching hospital - 1980-1989. Clin Infect Dis 1992; 14:29-37.
4. The work group on severe streptococcal infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 269:390-1.
5. Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988; 158:23-8.
6. Eagle H. Experimental approach to the problem of treatment failure with penicillin: I. group A streptococcal infection in mice. Am J Med 1952; 13:389-99.
7. Maruyama S, Yoshioka H, Fujita K, Takimoto M, Satuke Y. Sensitivity of group A streptococci to antibiotics: prevalence of resistance to erythromycin in Japan. Am J Dis Child 1979; 133:1143-5.
8. Henkel JS, Armstrong D, Blevins A, Moody MD. Group A β-hemolytic Streptococcus bacteremia in a cancer hospital. JAMA 1970; 211:983-6.
9. Trott KR, Kummermehr J. Radiation effects in skin. In: Scherer E, Streffer C, Trott KR, eds. Radiopathology of organs and tissues. Berlin, Springer-Verlag, 1991:33-66.
10. Garner IS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
11. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45: 493-6.
12. Jones RN, Baeey AL, Gavan TL, et al. Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard: vol 4. 3rd edn. Villanova Pennsylvania, National Committee for Clinical Laboratory Standards, 1984:369-83.
13. Endo M, Kashiwagi Y, Okuno R. Antibiotics sensitivity and serotypes of group A hemolytic streptococci isolated from clinical specimens and healthy pupils in Japan, 1986-1988. J Jpn Assoc Infect Dis 1991; 65:919-27.
14. Katsukawa C, Harada K. Serotype and antibiotic susceptibilities of group A hemolytic streptococci isolated in Osaka, 1988-1989. J Jpn Assoc Infect Dis 1991; 65:945-52.
15. Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326:292-7.
16. Lentnek AL, Giger O, O'Rourke E. Group A β-hemolytic streptococcal bacteremia and intravenous substance abuse: a growing clinical problem? Arch Intern Med 1990; 150:89-93.
17. Ispahani P, Donald FE, Aveline AJD. Streptococcus pyogenes bacteremia: an old enemy subsided, but not defeated. J Infect 1988; 16:37-46.
18. Schwartz B, Elliot JA, Butler JC, Simon PA, Jameson BL, Welch GE, Facklam RR. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992; 15:277-84.
19. Keefer CS, Ingelfinger FJ, Spink WW. Significance of hemolytic streptococcic bacteremia: a study of two hundred and forty-six patients. Arch Int Med 1937; 60:1084-97.
20. Center for Disease Control. Nosocomial infection surveillance. 1984 MMWR 1986; 33(3ss):17-29.
21. Wong VK, Wright HT. Group A β-hemolytic streptococci as a cause of bacteremia in children. Am J Dis Child 1988; 142:831-3.
22. Wheeler MC, Roe MH, Kaplan EL, Schlievert PM, Todd JK. Outbreak of group A Streptococcus septicemia in children: clinical, epidemiological, and microbiological correlates. JAMA 1991; 266:533-7.
23. Dudding B, Humphrey B, Nesbit ME. Beta-hemolytic streptococcal septicemias in childhood leukemia. Pediatrics 1969; 43:359-64.
24. Elliott TB, Brook I, Stiefel SM. Quantitative study of wound infection in radiated mice. Int J Radiat Biol 1990; 58:341-50.
25. Charles D, Larsen B. Streptococcal puerperal sepsis and obstetric infections: a historical perspective. Rev Infect Dis 1986; 8:411-22.
26. Braunstein H. Characteristics of group A streptococcal bacteremia in patients at the San Bernardino county medical center. Rev Infect Dis 1991; 13:8-11.
27. Barg NL, Kish MA, Kauffman CA, Supena RB. Group A streptococcal bacteremia in intravenous drug abusers. Am J Med 1985; 78:569-74.
28. Geopel JR, Richards DG, Harris DM, Henry L. Fulminant Streptococcus pyogenes infection. Br Med J 1980; 281:1412.
29. Soravia C, Romand JA, Herrmann M, Chevrolet JC, Ricou B, Suter PM. Group A β-haemolytic Streptococcus septicaemia: the toxic strep syndrome - report of four cases developing septic shock and multiple organ failure. Intensive Care Med 1993; 19:53-6.
30. Sander E, Foster MT, Scott D. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med 1968; 278:538-40.
31. Hsueh PR, Chen HM, Huang AH, Wu JJ. In vitro antimicrobial susceptibility and T-antigen patterns of Streptococcus pyogenes. Annual Meeting of Infectious Diseases Society of R.O.C. Taipei, Taiwan, R.O.C. 1994.
32. Tanz RR, Poncher JR, Corydon KE, Kabat K, Yogev R, Shulman ST. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 1991; 119:123-8.
33. Deguchi K, Yokota N, Koguchi M, Suzuki Y, Suzuki K, Fukayama S, et al. Antibacterial activity of rokitamycin against fresh clinical isolates. Jpn J Antibiot 1992; 45:1609-21.
34. Chang SC, Chen YC, Luh KT, Hsieh WC. In vitro activities of new macrolides against common bacteria isolated from Taiwan. Annual Meeting of Infectious Diseases Society of R.O.C. Taipei, Taiwan, R.O.C. 1994.
35. Wood TF, Potter MA, Jonasson O. Streptococcal toxic shock-like syndrome: the importance of surgical intervention. Ann Surg 1993; 217:109-14.